DenovAI Biotech
PrivateLast Round
Seed
Jan 8, 2024
Total Funding Raised
$2M
Company Overview
DenovAI Biotech operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in January 2024.
DenovAI Biotech is a biotechnology company that develops a generative artificial intelligence and physics platform for the de-novo design of therapeutic proteins, including antibodies and mini-proteins.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DenovAI Biotech Comparables
Compare DenovAI Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antiverse | 86% | |
| Onava | 86% | |
| immunitoAI | 85% |
For institutional investors. Book with your work email.
DenovAI Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2024 | ||||
| Pre Seed | Feb 28, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DenovAI Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Seed, Pre Seed |
| Israel Innovation Authority | Grant |
| Amiti Ventures | Seed, Pre Seed |
| Pfizer | Seed, Pre Seed |
| AION Labs | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 249% MoM, reaching 2K.
- Jan 8, 2024
Seed round included investors Pfizer and Amiti Ventures.
For institutional investors. Book with your work email.
DenovAI Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DenovAI Biotech's valuation, stock price, and market status.
Is DenovAI Biotech a public or private company?
DenovAI Biotech is a private company.
What is the current stock price of DenovAI Biotech?
DenovAI Biotech is a private company, so its shares have no public market price. Caplight tracks DenovAI Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DenovAI Biotech worth (valuation)?
Valuation information for DenovAI Biotech is not publicly available.
Can I buy DenovAI Biotech stock?
DenovAI Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DenovAI Biotech's last funding round?
DenovAI Biotech's most recent funding round was Seed on January 8, 2024.
Who are the main investors in DenovAI Biotech?
Key investors in DenovAI Biotech include Amiti Ventures, AION Labs.
Will DenovAI Biotech IPO soon?
No public IPO plans have been announced for DenovAI Biotech.
How can I track DenovAI Biotech secondary market activity?
Caplight tracks bids, offers, and trades in DenovAI Biotech's shares on secondary markets.